ACCORD HLTHCARE FDA Approval ANDA 210180

ANDA 210180

ACCORD HLTHCARE

FDA Drug Application

Application #210180

Application Sponsors

ANDA 210180ACCORD HLTHCARE

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL2.5MG0APIXABANAPIXABAN
002TABLET;ORAL5MG0APIXABANAPIXABAN

FDA Submissions

UNKNOWN; ORIG1AP2020-07-28STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ACCORD HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210180
            [companyName] => ACCORD HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/28\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-07-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.